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AbstractsASIT MEDAL: 0311: OESTROGEN RECEPTORS AND OESOPHAGEAL CAN-
CER: A POTENTIAL THERAPEUTIC PATHWAY
Waleed Al-Khyatt 2, Cristina Tufarelli 1, Raheela Khan 1, Syed Iftikhar 2.
1 School of Graduate Entry Medicine and Health, University of Nottingham,
Royal Derby Hospital, Derby, UK; 2Division of Surgery, Royal Derby Hospital,
Derby, UK.
Introduction: Oestrogen receptors (ER) have a well-established link in the
initiation, progression and response to treatment of some cancers. Little is
known, however, about the signiﬁcance of ER as therapeutic biomarkers in
oesophageal cancer (OC).
Methods: Effects of ER modulators on proliferation in OE33 and OE19 OC
cells was evaluated. ERa and ERb expression in paired normal and tumour
oesophageal samples (n ¼ 34) was performed using RT-qPCR. Correlation
between ERmRNA expression and clinico-pathological features for OC was
determined.
Results: There was a signiﬁcant dose dependent inhibition of proliferation
in OE33 and OE19 OC cells by a highly selective ERa antagonist (MPP) and
an ERb speciﬁc antagonist (PHTPP) (p <0.05). RT-qPCR analysis revealed
that ERa and ERb mRNA expression was signiﬁcantly higher (p<0.05) in
tumour tissues relative to their paired normal mucosa. Expression of ERa
and ERb in tumour samples correlated inversely with survival outcome
(p<0.05). Up-regulation of ERa correlated with higher pathological T stage
(p<0.05) and lymph node metastasis (p<0.05), while ERb up-regulation
correlated with positive vascular invasion (p<0.05).
Conclusions: Our ﬁndings indicate a role for ER in the biological behaviour
of OC. Hence, the ER system may provide an additional novel target for the
treatment of OC.
ASIT MEDAL: 0853: ASIT ANSELL MEDAL PRIZEWINNER: HUMANAMNI-
OTIC EPITHELIAL CELLS MODULATE ALLOREACTIVE T-CELL ACTIVITY: A
POTENTIAL ADJUNCT TO CELLULAR TRANSPLANTATION
Khalid Qureshi, Jou-Ann Lee, Michelle Paget,
Hilary Murray, Richard Downing. The Islet Research Laboratory,
Worcestershire, UK.
Introduction: Human amniotic epithelial cells (AEC) display immuno-
modulatory properties. We have previously demonstrated that bio-engi-
neered transplantable constructs formed by co-culturing human islets and
AEC (islet:AEC) exhibit markedly reduced immunogenicity in contact with
peripheral blood mononuclear cells (PBMC) compared to unmodiﬁedislets, which is likely to reduce their vulnerability to graft rejection. To
extend these ﬁndings we now provide evidence that distinct T-cell sub-
populations, implicated in allograft destruction, are targets for AEC
immunomodulation.
Methods: Magnetic assisted cell sorted CD4+ and CD8+ T-cells were
cultured alone or in contact with human AEC, islets or islet:AEC constructs,
using CD3/CD28 to induce physiological activation and expansion. The
degree of allo-reactivity viz. T-cell proliferation was assessed by chem-
iluminescence assay.
Results: CD4+ and CD8+ T-cell proliferation was responsive to AEC co-
culture with CD3/CD28 activation being dose-dependently reduced
(p<0.05). CD4+ and CD8+ proliferation was also markedly attenuated on
contact with islet:AEC constructs compared to that observed with un-
modiﬁed islets (p < 0.05).
Conclusion: T-cells that are known to mediate allograft rejection in cell
transplantation are modulated by AEC. AEC may therefore serve as an
adjunct in cell transplantation, reducing the requirement for chronic sys-
temic immunosuppression and promoting long-term graft survival.ASIT MEDAL: 0921: PROSPECTIVE STUDY TO ASSESS TUMOUR NECROSIS
FACTOR ALPHA IN NON-INFLAMMATORY BOWEL DISEASE ENTEROCU-
TANEOUS FISTULA
Goher Rahbour 1, Haﬁd O. Al-Hassi 2, Ailsa L. Hart 1, Muhammad R. Ullah 1,
Simon M. Gabe 1, Stella C. Knight 2, Janindra Warusavitarne 1,
Carolynne J. Vaizey 1. 1 St. Mark's Hospital and Academic Institute, London,
UK; 2Antigen Presentation Research Group, Imperial College, London, UK.
Aim: Tumour necrosis factor alpha (TNF-a) is elevated in inﬂammatory
bowel disease enterocutaneous ﬁstula (IBD ECF). No study has assessed the
level in non-IBD ECF. The aim of this study was to assess the inﬂammatory
activity, with a particular emphasis on TNF-a in non-IBD ECF when
compared with control small bowel tissue.
Methods: Tissue biopsies were obtained from ECF at operation from non-
IBD patients and from normal control patients. After overnight culture,
intracellular staining was performed using monensin to assess on-going
production of TNF-a. Data was acquired using FACS Canto II. Unpaired
Student's t-test was used to compare variables between groups.
Results: The on-going production of TNF-a from dendritic cells (p ¼
0.0007), putative monocyte and B cell populations (p ¼ 0.04) and CD3+ T
cells (p ¼ 0.04) was signiﬁcantly higher than that from control tissue.
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ABSTRACTSConclusions: This study reveals encouraging results and may provide
evidence for the potential use of anti-TNF-a agents in the treatment of
non-IBD ECF. Recommendations are for a pilot study to assess whether this
can be an alternative option to beneﬁt an already surgically challenging
group of patients. Positive ﬁndings would equate to a major medical
advance with a new use for anti-TNF-a agents.ASIT MEDAL: 1281: A NOVEL NEAR INFRARED EMITTING FLUORESCENT
NANOPARTICLE FOR SENTINEL LYMPH NODE BIOPSY
Sarwat Rizvi 1, Shohei Taniguchi 2, Mark Green 2, Alexander Seifalian 1,
Mohammed Keshtgar 1. 1Centre of Nanotechnology & Regenerative Medicine,
Division of Surgery and Interventional Sciences, University College London,
London, UK; 2Department of Physics, King's College London, London, UK.
Background: Quantum dots (QDs) are ﬂuorescent nanoparticles with
unique photophysical properties that can potentially replace the current
tracers for Sentinel Lymph Node Biopsy (SLNB) including the blue dye and
radiocolloid that have various limitations. Near Infra Red (NIR) emitting
QDs can be tracked in deep tissues as biological tissues are transparent to
these wavelengths. We have developed NIRQDs as alternative probes for
SLNB and set up a live NIR imaging system to track them in vivo.
Materials & Methods: NIRQDs (CdTe/CdS/ZnSe) were synthesized and
characterized using various techniques. 100mL of QDs were co-injected
with blue dye into the hind legs of rat models (n¼4) and compared to
controls (n¼4) which were injected with blue dye only. QDs were tracked
using a live NIR imaging system that was set up in house.
Results: NIRQDs emitted at 720nm and were visualised by the live NIR
imaging system as they entered the lymphatics after injection. The lym-
phatics converged to the groin and a small surgical incision at this site
revealed the underlying sentinel lymph node with minimal dissection.
Conclusion: NIR emitting QDs can be used for accurate localisation of the
SLN prior to surgical incision, making this an even more minimally inva-
sive procedure.ASIT MEDAL: 1344: ISOLATED LIMB PERFUSION WITH MELPHALAN,
TNFA AND ONCOLYTIC VACCINIA VIRUS DELAYS TUMOUR GROWTH
AND PROLONGS SURVIVAL IN A RAT MODEL OF LOCALLY-ADVANCED
EXTREMITY SARCOMA
Tim Pencavel 1, Rohit Seth 2, Aadil Khan 2, Michelle Wilkinson 1,
Andrew Hayes 1, Kevin Harrington 2. 1 Sarcoma/Melanoma Unit, Royal
Marsden Hospital, London, UK; 2 Targeted Therapy Team, The Institute of
Cancer Research, London, UK.
Aim: Isolated Limb Perfusion (ILP) is used for extremity sarcoma and in-
transit melanoma. Adding oncolytic viruses may improve the efﬁcacy of
both treatments, and raises the possibility of locoregional therapy priming
a systemic immune response.
Preclinical studies were performed to establish: feasibility of the model;
additional therapeutic effect of Vaccinia virus (VV); and preclinical data to
support a clinical trial.
Method: In vitro assays quantiﬁed single-agent and combinatorial activ-
ities of melphalan, TNFa and VV against sarcoma and melanoma cells. An
immunocompetent rat extremity sarcoma model was developed to eval-
uate tumour response, survival, biodistribution and toxicity of VV.
Results: The combination of melphalan/VV was synergistic in vitro. Triple-
therapy ILP was well tolerated, and resulted in prolonged survival and
tumour growth delay in both microscopic and established tumour models
compared to doublet, by 50% in established tumours (24 vs 16 days,
p¼0.0001). Virus was recoverable from perfused regions, and titres
recovered indicated successful viral replication.
Conclusions: The addition of VV to TNFa/Melphalan ILP regimens in-
creases survival. No extra morbidity occurred as a result. Normal organs
were not infected. A Phase 1 trial of VV by ILP is undergoing ethical and
regulatory scrutiny, with the aim of commencing recruitment in 2013.ASIT MEDICAL STUDENT PRIZE: 0215: ASIT/ELSEVIER MEDICAL STU-
DENT PRIZE WINNER: A COMPARATIVE STUDY USING ULTRASOUND
(US) AND CLINICAL PALPATION TO EVALUATE EASE OF VASCULAR AC-
CESS WITH DIFFERENT PELVIC BINDERS IN HEALTHY VOLUNTEERS
Rozina Mahmood, Anna Lygas, Nnambi Obi, Nick Green, Shakeel Rahman,
Rhodri Evans, Ian Pallister. Morriston Hospital, Swansea, UK.Background: Mortality from haemorrhage associated with pelvic ring in-
juries remains high. Immediate application of a pelvic binder is a crucial step
in damage control resuscitation (DCR) for these patients. Therapeutic angi-
ography isa furthereffective intervention formanagingarterialhaemorrhage
andtheCommonFemoralartery (CFA) is thepreferredsite for vascularaccess.
Aim: To determine which binder design provides greatest access to the
femoral vessels for therapeutic angiography in a group of healthy
volunteers.
Method: Four different binders, the T-POD, SAM-Sling, Prometheus and
Improvised binder were applied correctly to fourteen volunteers. Access to
the femoral vessels was assessed by attempting to palpate the femoral
pulse, and by using US, performed by a consultant radiologist, to determine
whether the CFA and Superﬁcial femoral artery (SFA) were detectable and
their depth. Volunteer Body Mass Indices were also recorded.
Results: Successful palpation of femoral pulse: SAM-Sling 57%, T-POD 7%,
Promethus 29% and Improvised binder 36%. CFA identiﬁed on US: SAM-
Sling 43%, T-POD 0%, Promethus 0%, and Improvised binder 29%. SFA
identiﬁed on US: SAM-Sling 64%, T-POD 100%, Promethus 100% and
Improvised binder 71%.
Conclusion: The SAM-Sling and Improvised binder allowed better access
to the CFA, in both normal and overweight individuals.ASIT MEDICAL STUDENT PRIZE: 0364: THE USE OF SYMNOSE FOR THE
QUANTITATIVE ASSESSMENT OF LIP SYMMETRY FOLLOWING REPAIR
OF COMPLETE BILATERAL CLEFT LIP AND PALATE
James Russell, Harriet Kiddy, Nigel Mercer. Frenchay Hospital, Bristol, UK.
Aim: The SymNose computer program has been proposed as an objective
method for the quantitative assessment of lip symmetry following uni-
lateral cleft lip repair. This study aims to demonstrate the use of SymNose
in patients with bilateral complete cleft lip and palate (BCLP), a group
previously excluded from computer-based analysis.
Method: A retrospective cohort study compared several parameters of lip
symmetry between BCLP cases and non-cleft controls. 15 BCLP cases aged
10 (1 year) who had undergone primary repair were recruited from the
patient database at the South West Cleft Unit, Frenchay. Frontal facial
photographs were selected for measurement. 15 age-matched controls
were recruited from a local school. Lip symmetry was expressed as: per-
centage mismatch of left vermillion border and upper lip area over the
right, horizontal lip tilt and lateral deviation of the lip.
Results: A signiﬁcant increase in lip asymmetry was found in the BCLP
group expressed as upper vermillion border mismatch across computer-
deﬁned and user-deﬁned midlines (mean difference was 16.4% (p<0.01)
and 17.5% (p<0.01) respectively).
Conclusions: The results suggest that a signiﬁcant degree of lip asym-
metry remains in BCLP patients even after primary repair. This challenges
previous assumptions that those with bilateral defects would be relatively
symmetrical.ASIT MEDICAL STUDENT PRIZE: 0433: PAIN AFTER TOTAL KNEE
REPLACEMENT (TKR). A RANDOMISED CONTROLLED TRIAL OF LOCAL
INFILTRATION VERSUS SINGLE SHOT FEMORAL NERVE BLOCK
Anam Ashraf, George McLauchlan, Videsh Raut, Steven Canty. Lancashire
Teaching Hospital, Preston, UK.
Background: Multiple modalities can be used to manage pain after TKR.
There are no studies of local joint inﬁltration versus single shot femoral
nerve block.
Objectives: We conducted an ethically approved prospective blinded
randomised trial. We aimed to identify whether local inﬁltration gave
better postoperative pain relief compared to standard practice of single
shot femoral nerve block.
Methods: 40 patients undergoing a primary TKR underwent a stand-
ardised spinal anaesthetic and where then randomised to one of two
groups. Outcomes measured included postoperative pain scores, pain
scores before and after physiotherapy on postoperative day 1, analgesia
used postoperatively, time to achieve physiotherapy goals and length of
hospital stay.
Results: The local inﬁltration group had signiﬁcantly lower pain scores
postoperatively (mean [SD] 2.1[2.6] vs 6.8[3.2], p<0.0001) and on post-
operative day one prior to physiotherapy (mean [SD] 2.9[2.3] vs 4.4[2.3],
p<0.05). Total opiate use was signiﬁcantly lower in the inﬁltration group
